Glioblastoma, IDH-Wildtype — Trials

Glioblastoma, IDH-Wildtype — Trials · CancerIndex

Clinical trials

Registered studies

303 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 76
Recruiting: 42
Ph III recruiting: 3
Growth YoY: —
Industry share: 12%
Top sponsor: Mayo Clinic
Termination share: 43.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (64)

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01903330	ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme	unknown	Phase 2	84	Epitopoietic Research CorporationINDUSTRY	1	Mar 5, 2025	clinicaltrials
NCT05694416	Etoposide Plus Cisplatin Compared With Temozolomide in Patients With Glioblastoma	unknown	Phase 2	60	Zhongnan HospitalOTHER	0	Jan 23, 2023	clinicaltrials